YOUR MAP TO BETTER MONITORING Trademark

Trademark Overview

On Wednesday, July 11, 2012, a trademark application was filed for YOUR MAP TO BETTER MONITORING with the United States Patent and Trademark Office. The USPTO has given the YOUR MAP TO BETTER MONITORING trademark a serial number of 85674232. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 15, 2025. This trademark is owned by Allphase Clinical Research Services Inc.. The YOUR MAP TO BETTER MONITORING trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing quality assurance services in the conduct of clinical trials and clinical trial investigation protocols, plans, and systems used therefor, for the purpose of verifying compliance with national and international norms, laws, rules, practice and standards within the clinical trial industry; consulting services for others in the field of design, planning, and implementation project management in the conduct of clinical trials; assessment of the progress of clinical trials and compliance with study protocols, policies, procedures and regulatory requirements; scientific investigations in the nature of investigation of clinical trials for medical purposes, providing medical and scientific research relating to research gap analyses and needs assessment analyses in the field of clinical trials

General Information

Serial Number85674232
Word MarkYOUR MAP TO BETTER MONITORING
Filing DateWednesday, July 11, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 15, 2025
Registration Number4680455
Registration DateTuesday, February 3, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 18, 2014

Trademark Statements

Goods and ServicesProviding quality assurance services in the conduct of clinical trials and clinical trial investigation protocols, plans, and systems used therefor, for the purpose of verifying compliance with national and international norms, laws, rules, practice and standards within the clinical trial industry; consulting services for others in the field of design, planning, and implementation project management in the conduct of clinical trials; assessment of the progress of clinical trials and compliance with study protocols, policies, procedures and regulatory requirements; scientific investigations in the nature of investigation of clinical trials for medical purposes, providing medical and scientific research relating to research gap analyses and needs assessment analyses in the field of clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSaturday, August 16, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAllphase Clinical Research Services Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressOttawa, Ontario K2V1C8
CA
Party NameAllphase Clinical Research Services Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOttawa, Ontario K2K2E3
CA
Party NameAllphase Clinical Research Services Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOttawa, Ontario K2K2E3
CA

Trademark Events

Event DateEvent Description
Tuesday, November 6, 2012NON-FINAL ACTION E-MAILED
Wednesday, July 18, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 1, 2012ASSIGNED TO EXAMINER
Tuesday, November 6, 2012NON-FINAL ACTION WRITTEN
Tuesday, November 6, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 21, 2013SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, April 30, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 1, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 3, 2013ASSIGNED TO LIE
Monday, May 13, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 13, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 16, 2013SUSPENSION LETTER WRITTEN
Thursday, May 16, 2013LETTER OF SUSPENSION E-MAILED
Thursday, May 16, 2013NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, September 12, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 21, 2013SUSPENSION INQUIRY WRITTEN
Thursday, November 21, 2013INQUIRY TO SUSPENSION E-MAILED
Thursday, November 21, 2013NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, February 17, 2014TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, February 17, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 17, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 13, 2014PRIORITY ACTION WRITTEN
Thursday, March 13, 2014PRIORITY ACTION E-MAILED
Thursday, March 13, 2014NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, February 3, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, December 31, 2020TEAS SECTION 8 & 15 RECEIVED
Tuesday, September 23, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 23, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 16, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 16, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 29, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 18, 2014PUBLISHED FOR OPPOSITION
Tuesday, November 18, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 3, 2015REGISTERED-PRINCIPAL REGISTER
Thursday, May 25, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, February 3, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, August 15, 2025CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Tuesday, April 20, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, April 20, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 20, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Related Keywords

monitoring better your clinical trials research medical assessment providing scientific compliance protocols field